Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

BOM/536565 stock hub

BOM/536565 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/536565is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/536565

In the news

Latest news · BOM/536565

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E45.5

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC7.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/536565 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

INR

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	8
Employees Change	1%
Employees Change Percent	14.29
Enterprise value	INR 1.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	INR 1.1B
Price	INR 54.55
Price currency	INR
Rev Per Employee	160,006,375x
Sic	5122
Symbol	bom/536565
Website	https://novelixpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.66%
EV Earnings	59.42x
EV/EBIT	44.99x
EV/EBITDA	44.28x
EV/Sales	0.84x
P/B ratio	4.25x
P/E ratio	45.52x
P/S ratio	0.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.86%
EBITDA Margin	1.89%
Gross margin	3.04%
Gross Profit	INR 38.9M
Gross Profit Growth	315.45%
Gross Profit Growth Q	456.88%
Gross Profit Growth3 Y	58.57%
Gross Profit Growth5 Y	19.88%
Net Income	INR 18.1M
Net Income Growth	802.31%
Net Income Growth Q	579.11%
Pretax Margin	1.86%
Profit Margin	1.41%
Profit Per Employee	INR 2.3M
Roa5y	-4.52
Roe5y	-13.53
ROIC	7.48
Roic5y	-11.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	22.37%
Cagr15y	4.81%
Cagr1y	105.1%
Cagr3y	72.63%
Cagr5y	41.44%
EPS Growth	458.7
EPS Growth Q	286.7
Revenue Growth	1,084.24x
Revenue Growth Q	813.1x
Revenue Growth3 Y	127.02x
Revenue Growth5 Y	64.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 14.5M
Equity	INR 256.1M
Net Cash	INR 14.5M
Net Cash By Market Cap	INR 1.33
Net Cash Growth	855.66%
Net Debt EBITDA	INR -0.6
Net Debt Equity	INR -0.06
Tangible Book Value	INR 249M
Tangible Book Value Per Share	INR 17.28
WACC	6.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-63.39%
Dividend per share	INR 0
Last Dividend	INR 0.3

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	652.41%
1Y total return	105%
200-day SMA	52.04
3Y total return	414.62%
50-day SMA	55.76
50-day SMA vs 200-day SMA	50over200
5Y total return	465.87%
All Time High	74.6
All Time High Change	-26.88%
All Time High Date	2010-01-12
All Time Low	1.85
All Time Low Change	2,848.65%
All Time Low Date	2020-03-03
ATR	4.57
Beta	0.37
Beta1y	0.42
Beta2y	0.32
Ch YTD	-12.89
High	58.7
High52	70.16
High52 Date	2025-11-19
High52ch	-22.25%
Low	53.02
Low52	27.94
Low52 Date	2025-06-02
Low52ch	95.24%
Ma50ch	-2.16%
Price vs 200-day SMA	4.83%
RSI	47.07
RSI Monthly	73.67
RSI Weekly	51.48
Sharpe ratio	1.96x
Sortino ratio	3.32
Total Return	-63.39%
Tr YTD	-12.89
Tr15y	102.38%
Tr1m	8.49%
Tr1w	-0.6%
Tr3m	-14.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 23.9M
Operating Income Growth	1,447.6
Operating Income Growth Q	903.2
Operating margin	1.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,283,616%
Shares Insiders	39.05%
Shares Institutions	1.25%
Shares Out	19,935,000
Shares Qo Q	20.19%
Shares Yo Y	63.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	4,257.05x
Bv Per Share	17.77
Ch10y	652.4
Ch15y	96.93
Ch1m	8.49
Ch1w	-0.6
Ch1y	105
Ch3m	-14.43
Ch3y	414.6
Ch5y	465.9
Ch6m	2.93
Change	0%
Change From Open	-7.07
Close	54.55
Days Gap	7.61
Depreciation Amortization	378,725
Dollar Volume	290,424.2
Earnings Date	2026-05-26
EBIT	INR 23.9M
EBITDA	INR 24.2M
EPS	INR 1.2
F Score	1
Fiscal Year End	March
Founded	1,994
Graham Number	21.89169
Graham Upside	-59.87
Income Tax	INR 5.8M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2010-10-04
Last Split Type	Reverse
Ma150	55.53
Ma150ch	-1.76%
Ma20	55.89
Ma20ch	-2.39%
Next Earnings Date	2026-05-26
Open	58.7
Position In Range	26.94
Price Date	2026-05-08
Price EBITDA	INR 44.88
Ptbv Ratio	4.37
Relative Volume	1.25x
Revenue	1,280,051,000x
Tax By Revenue	0.45x
Tax Rate	24.2%
Tr6m	2.93%
Volume	5,324

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/536565 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/536565 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/536565?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.3%

Share of float held by funds and institutions

Insider ownership

+39.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+63.4%

Negative means the company is buying back shares.

Technical

BOM/536565 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.1

Neutral momentum band

Price vs 200-day MA

+4.8%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

1.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/536565

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/536565 stock rating?

bom/536565 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/536565 analysis?

The full report lives at /stocks/bom/536565/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/536565?

The latest report frames bom/536565 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/536565 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.